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Abstract
Background: Angiogenesis and vascular remodelling are crucial events in tissue repair mechanisms promoted by cell
transplantation. Current evidence underscores the importance of the soluble factors secreted by stem cells in tissue
regeneration. In the present study we investigated the effects of paracrine factors derived from cultured endothelial
progenitor cells (EPC) on rat brain endothelial cell properties and addressed the signaling pathways involved.
Methods: Endothelial cells derived from rat brain (rBCEC4) were incubated with EPC-derived conditioned medium (EPC-CM).
The angiogenic response of rBCEC4 to EPC-CM was assessed as effect on cell number, migration and tubular network
formation. In addition, we have compared the outcome of the in vitro experiments with the effects on capillary sprouting
from rat aortic rings. The specific PI3K/AKT inhibitor LY294002 and the MEK/ERK inhibitor PD98059 were used to study the
involvement of these two signaling pathways in the transduction of the angiogenic effects of EPC-CM.
Results: Viable cell number, migration and tubule network formation were significantly augmented upon incubation with
EPC-CM. Similar findings were observed for aortic ring outgrowth with significantly longer sprouts. The EPC-CM-induced
activities were significantly reduced by the blockage of the PI3K/AKT and MEK/ERK signaling pathways. Similarly to the
outcome of the rBCEC4 experiments, inhibition of the PI3K/AKT and MEK/ERK pathways significantly interfered with capillary
sprouting induced by EPC-CM.
Conclusion: The present study demonstrates that EPC-derived paracrine factors substantially promote the angiogenic
response of brain microvascular endothelial cells. In addition, our findings identified the PI3K/AKT and MEK/ERK pathways to
play a central role in mediating these effects.
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Introduction
Extensive investigations are currently carried out to achieve
replacement of damaged cells and tissue repair through cell
transplantation [1–3]. Despite the experimental evidence of the
beneficial use of stem and progenitor cells as therapeutic tools,
their mechanisms of action are still not completely understood.
Endothelial Progenitor Cells (EPC) hold great promise in the field
of regenerative medicine. EPC are bone marrow-derived cells
which play a critical role in the maintenance of endothelial
homeostasis and contribute to physiological or pathological
postnatal neovascularization. EPC are mobilized from the bone
marrow into peripheral blood in response to chemoattractants
released by ischemic or damaged tissues. Recent data suggest that
the regenerative properties are not limited to vascularization and
re-endothelization, but it is now evident that EPC can support
tissue repair processes also in paradigms different form cardiovas-
cular tissue as skin and neuronal tissue [4,5]. In fact, there is
compelling evidence that differentiation and incorporation into
nascent vessels account only in part for the EPC actions and it is
widely recognized that EPC-derived paracrine signals play a
pivotal role in orchestrating the repair processes in damaged
tissues [6,7]. In line with this notion, considerable regenerative
effects including increased neuronal plasticity have been detected
after cell transplantation despite lack of neuronal differentiation
[8]. Hence, soluble factors released from the graft are considered
the key players in restorative cell transplantation approaches [9]
and likely explain the apparent paradox in several paradigms of
tissue regeneration with negligible engraftment of transplanted
precursors into the host tissue [10]. We and others have previously
reported that EPC secrete a large array of factors with
immunomodulatory and angiogenic properties [11,12]. In this
context we have demonstrated that EPC-derived conditioned
medium (EPC-CM) enhances mature endothelial cell viability
[13]. Most importantly, the cocktail of trophic factors presented in
EPC-CM has displayed remarkable therapeutic capacity compa-
rable to cell transplantation in a model of hind limb ischemia in
rats [11] and in a mouse stroke model [14]. A detailed description
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of EPC secretome has been reported [15] but the manner in which
this complex mixture of factors modulates the activities of target
cells at a molecular level remains elusive.
In endothelial cells PI3K/AKT and MEK/ERK signaling
pathways play a primary role in the transduction of mitotic and
pro-survival signals of many growth factors and cytokines (for
review see [16,17]). Angiogenesis and neurogenesis are coupled
processes [18] and the intimate anatomical and physiological
interaction of the nervous and vascular system pinpoints the
importance of a functional vascular network for the maintenance
of nervous tissue functions. As matter of fact, dysfunctions at the
(micro)vascular level accompany neuronal degeneration in neuro-
degenerative disorders [19,20]. As a corollary of these observa-
tions, it can be envisioned that interventions aimed to support
endothelial functions and to promote revascularization not only
might facilitate the restoration of appropriate tissue perfusion in
cases of ischemia but also effectively enhance repair mechanisms
in the nervous tissue [21].
In the present study we have investigated whether EPC-CM
induces an angiogenic response in brain microvascular endothelial
cells and assessed whether these effects might be mediated by
PI3K/AKT and MEK/ERK pathways.
Materials and Methods
Endothelial cell culture
The rat brain microvascular cell line rBCEC4 was kindly
provided by Dr. I. Blasig (Forschungsinstitut fu¨r Molekulare
Pharmakologie, Berlin, Germany). rBCEC4 cells are derived by
stable transfection and immortalization of rat brain microvascular
endothelial cells with large T antigen of polyoma virus [22].
rBCEC4 cells show conserved properties of primary cells including
an epitheloid morphology and the expression of endothelial and
blood brain barrier markers. In addition, due to their formation of
tight endothelial monolayers they are suitable for pharmacokinetic
studies [22]. Cells were grown on 1% gelatin (Bio-Rad) coated
plates in DMEM containing 5% Fetal Bovine Serum (FBS, Gibco),
1% antibiotics/antimycotics (Sigma), 1.2 mM glutamine (Invitro-
gen), 100 ug/ml heparin (Sigma) and 10 ug/ml endothelial cell
growth factor (ECGF, Millipore), pH 7 in a humidified incubator
at 37uC and 5% CO2.
EPC culture and conditioned medium preparation
EPC were isolated from healthy donors peripheral blood using
buffy coats purchased from the local Blood Bank (Blutspendedienst
Bern) in accordance with previously published methods [23].
Mononuclear cell fraction was isolated by Ficoll gradient
centrifugation using Histopaque (Sigma) and seeded on culture
dishes coated with human fibronectin (10 mg/cm2, Sigma). The
cultures were maintained in endothelial cell basal medium-2
(EBM-2) (Lonza) supplemented with endothelial growth medium
SingleQuots and 5% FBS. After 4 days in culture, adherent cells
were passaged and cultured through day 7 to obtain early
outgrowth EPC. To produce EPC-CM, EPC were washed three
times with PBS and incubated in growth factor-free EBM-2
containing 1% FBS for 48 hours under normoxic (21% O2, 5%
CO2, 93.5% N2) or hypoxic conditions (1.5% O2, 5% CO2,
93.5% N2). A humidified gas-sorted anoxic incubator-gloved box
(InVivo2 400, Ruskin) was used for hypoxic cultures. After
incubation, the conditioned medium was collected and centrifuged
at 10000 rpm at 4uC, the supernatant was sterile filtered and snap-
frozen until use [11]. EBM-2 containing 1% FBS was treated in
parallel to the cell cultures and served as control medium.
Cytokine array
Presence of angiogenic growth factors in EPC-CM was screened
using a Human Angiogenesis Antibody Array (RayBiotech) as
previously described [13]. The chemiluminescent signal of each
factor on the array was acquired by ChemiDoc XRS (Bio-Rad)
and the intensity measured by densitometry analysis using ImageJ
(http://rsbweb.nih.gov/ij/).
Western Blot analysis
Two hundred thousand rBCEC4 grown in 6 well plates were
incubated with control medium or EPC-CM for 15 min. The
phosphorylation inhibitors [5 mM] LY294002 or [10 mM]
PD98059 were administered 30 min prior and during exposure
to EPC-CM. Following treatments, the cells were washed 3 times
with cold HBSS and lysed in RIPA buffer (Pierce Biotechnology,
Rockford, IL, USA) containing Protease Inhibitor Cocktail Set V
(Calbiochem),1 mM Sodium Orthovanadate (Sigma), 10 mM
PMSF (Sigma) and 1 mM Leupeptin (Sigma). After centrifugation
the supernatant was collected and the protein concentration was
estimated using the BCA kit (Pierce Biotechnology). Equal amount
of proteins were resolved on a 12% polyacrylamide gel followed by
overnight transfer and hybridization with primary antibodies:
mouse anti total AKT (Cell Signaling), rabbit anti pAKT (Cell
Signaling), mouse anti total ERK (Millipore), rabbit anti pERK
(Millipore). As secondary antibodies Dylight-800 anti mouse and
Dylight-680 anti rabbit were used. Immunoreactive bands were
visualized using an Odissey CLx scanner (LI-COR) equipped with
LI-COR Image. Quantification was performed on grey values
converted images using the software ImageJ.
Cell viability assay
Ten thousand rBCEC4 were seeded into 24 well plates and
cultured as described above. Before treatment the cells were
starved in EBM-2 containing 1% FBS for 24 hours. The cells were
then exposed to EPC-CM in presence or absence of [5 mM]
LY294002 and [10 mM] PD98059. After 24 hours the number of
viable cells was assessed by the Presto Blue assay (Invitrogen)
following the manufacturer’s indications using a microplate
fluorometer (Tecan Infinite 1000).
Scratch Wound assay
Confluent rBCEC4 cultures were grown on 24 well plates,
starved 8 hours in EBM2 medium containing 1% FBS. Thirty
minutes before the EPC-CM treatment, cultures were incubated
with [5 mM] LY294002 or [10 mM] PD98059 as indicated.
Wounds were created by scratching the monolayer with a
micropipette tip. Subsequently the cells were washed with PBS
to remove not attached cells and incubated with the media
according the assigned experimental group. Images were taken
immediately after the scratch and 8 hours after the treatment with
an inverted microscope (Nikon) equipped with a digital camera
(Motic). The wound healing index was calculated by measuring
the difference between the initial and final wound area using
ImageJ software.
In vitro tubular structure formation
The morphogenic capacity of rBCEC4 in vitro was assessed as
previously described [24]. Melted growth factor reduced Matrigel
(Becton Dickinson) was layered in 24 well plates and let to harden.
Forty thousand cells were resuspended in control, as well as the
other experimental culture media and seeded on the Matrigel
layer. After 16 hours of incubation, the formation of endothelial
cell tubular structure was assessed. Digital microphotographs were
Paracrine Factors and Brain Microvascular Cells
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taken at low magnification with a light microscope from three
randomly selected fields for data analysis. The angiogenic response
of rBCEC4 was assessed measuring the total length, the number of
branches and the area covered by the tubular structures with the
aid of ImageJ software.
Aortic ring assay
The sprouting from rat aortic rings was performed as previously
described with minor modifications [11,25,26]. Animal experi-
ments were performed in accordance with institutional guidelines
and regulations. The procedures were approved by the Animal
Research Ethics Committee of the Canton Berne Switzerland
(permission number 85/10), and the University of Bern Animal
Care and Use Committee, Switzerland. Briefly, adult female
Wistar rats were anesthetized using an induction gas inhalation
(4.5–5% Isoflurane, 75% N2O, 20% O2) followed by an i.p.
injection with Ketamine (120 mg/kg body weight) and Xylazine
(20 mg/kg body weight). In deep anesthesia the thoracic aorta was
removed and then dissected free of perivascular adipose tissue,
finally tissues were cut into 1 mm thick rings. Individual rings were
placed in 24 well plates coated with growth factor reduced
Matrigel (Becton Dickinson) and incubated with EPC-CM or
control medium in presence or absence of the inhibitors. After 5
days of culture, digital microphotographs were taken from two
randomly selected microscopic fields and analyzed with image J
software. In each image, the angiogenic response was expressed as
the total length of sprouts emerging from the aortic rings
normalized for the circumference the aortic ring visualized in
the image.
Statistical analysis
For statistical analysis, a commercially available software
package was used (Prism; GraphPad Software). One-way ANOVA
followed by Tukey’s multiple comparison test was used to compare
group means, after testing for normality and equal variance of the
data. Statistical significance was inferred at a 2-sided P # 0.05. All
experiments were performed in at least triplicates. Data are
presented in percentage relative to the controls and values are
given as mean 6 standard error of the mean (s.e.m.).
Results
EPC-CM is composed of a mixture of angiogenic factors
We have used an antibody array to assess the composition of
angiogenic growth factors in EPC-CM (Figure 1A) obtained from
cultures incubated under standard or hypoxic conditions (1.5%
oxygen). As expected, hypoxia increased the EPC-CM concen-
tration of factors as angiogenin, EGF, bFGF, leptin, thrombopoi-
etin, PDGF-BB, VEGF and VEGF-D. In contrast, RANTES was
higher in the normoxic EPC-CM while other factors did not
change in response to the oxygen level tested. Importantly, the
analysis of the basal medium used as control revealed the presence
of a very low basal level of angiogenic factors. For subsequent
experiments only EPC-CM from hypoxic cultures was used.
Figure 1. Cytokine Array. Presence of angiogenesis related factors in EPC-CM from normoxic (Normoxia) and hypoxic cultures (Hypoxia) was
assessed by ‘‘Human Angiogenesis Antibody Array’’ (A). The identity of the specific antibodies spotted on the membrane is described in the table
(B). Abbreviations: NEG: internal negative control; POS: internal positive control; ANG: angiogenin; ENA-78: epithelial-derived neutrophil-activating
peptide 78; EGF: epidermal growth factor; bFGF: basic fibroblast growth factor; GRO: Growth-regulated alpha protein; IFN c: interferon gamma; IL-6:
interleukin-6; IL-8: interleukin-8; MCP-1: monocyte chemoattractant protein-1; PDGF-BB: platelet-derived growth factor beta; PLGF: placental growth
factor; RANTES: regulated on activation, normal T cell expressed and secreted; TGF b1: Transforming growth factor beta 1; TIMP-1: tissue inhibitor of
metalloproteinase-1; TIMP-2: tissue inhibitor of metalloproteinase-2; THPO: thrombopoietin; VEGF: vascular endothelial growth factor A; VEGF-D:
vascular endothelial growth factor D.
doi:10.1371/journal.pone.0095731.g001
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EPC-CM induces activation of PI3K and MAPK pathway in
rBCEC4
We next reasoned whether the factors present in EPC-CM
could induce PI3K/AKT and MEK/ERK pathways activation in
brain microvascular endothelial cells. Protein lysates of rBCEC4
cultures treated with EPC-CM disclosed a time–dependent
activation of PI3K/AKT and MEK/ERK pathways with AKT
and ERK phosphorylation peaking at 15 minutes of incubation
(Fig. S1). Quantitative analysis of AKT and ERK phoshorylation
at this time point displayed a robust increase in rBCEC4 incubated
with EPC-CM (513.5 6 99.4% and 317 6 39.8% band intensities
relative to controls, for pAKT and pERK, respectively). As
expected, this effect was abrogated by co-incubation with the
respective inhibitors (to 129.1 6 20.1% and 133.5 6 22.7%
compared to controls, for pAKT and pERK, respectively) (Fig. 2).
rBCEC4 basal functions are not affected by PI3K/AKT or
MEK/ERK inhibition
We have conducted preliminary experiments in order to assess
whether the treatments with the PI3K/AKT or MEK/ERK
inhibitors would affect the basal functions of rBCEC4 under
control conditions (Fig. 3). Incubation of rBCEC4 in presence of
[5 mM] LY294002 or [10 mM] PD98059 did not significantly alter
Figure 2. EPC-CM activates AKT and ERK pathways. Representative immunoblots (A) and quantitative analysis (B) of rBCEC4 lysates incubated
with vehicle (Ctr) or EPC-CM (CM) in presence of either LY294002 (CM+LY) or PD98509 (CM+PD). Exposure of rBCEC4 to EPC-CM resulted in a marked
increase of both phosphorylated AKT and phosphorylated ERK (pAKT and pERK) with regards to the total AKT and ERK levels (tAKT and tERK).
Concomitant incubation with EPC-CM and the corresponding inhibitors almost completely blocked the phosphorylation of AKT and ERK. Data are
given as mean + s.e.m. and values are presented as percentage of corresponding controls. *: p , 0.05.
doi:10.1371/journal.pone.0095731.g002
Figure 3. Basal functions of rBCEC4 are not altered by LY294002 or PD98059. Viability (A), migration (B) and capacity to organize in tubular
structures (C) by rBCEC4 was not significantly changed compared to controls (Ctr) when incubated in presence of [5 mM] LY294002 or [10 mM]
PD98059. Data are given as mean + s.e.m. and values are presented as percentage of corresponding controls.
doi:10.1371/journal.pone.0095731.g003
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the viability (Fig. 3A), capacity to migrate (Fig. 3B) and form
tubular structures on Matrigel (Fig. 3C).
EPC-CM induces rBCEC4 viability
To examine whether soluble factors secreted by EPCs promote
endothelial cell viability, rBCEC4 were incubated with EPC-CM.
Administration of EPC-CM resulted in a significant increase of
viable cell numbers as compared to controls (to 150.9 6 6.0%). In
order to assess whether the effect on rBCEC4 viability is mediated
by AKT and/or ERK pathway, EPC-CM incubation was carried
out in absence or presence of the PI3K/AKT or MEK/ERK
inhibitors. Inhibition of the PI3K/AKT pathway with [5 mM]
LY294002 significantly reduced EPC-CM dependent cell number
raise (to 90.2 6 3.8%). Similarly, but to a minor extent, inhibition
of the MEK/ERK pathway with [10 mM] PD98059 resulted in
significantly lower viable cell numbers (to 120.5 6 6.9%) (Fig. 4).
EPC-CM supports wound closure through PI3K/AKT and
MEK/ERK pathway
The capacity of EPC-CM to enhance cell migration was
assessed by a scratch wound assay. Cultures incubated with EPC-
CM displayed substantially accelerated wound closure compared
to control (by 206.0 6 19.7%). Treatment with the PI3K/AKT or
MEK/ERK pathways inhibitors ([5 mM] and [10 mM], respec-
tively) significantly decreased but did not completely block the
EPC-CM-induced migration (to 149.7 6 16.4% and 155.0 6
14.1% relative to control group, respectively) (Fig. 5).
EPC-CM promotes tube formation through PI3K/AKT and
MEK/ERK activation
EPC-CM considerably enhanced the capacity of rBCEC4
to form tubular structures on Matrigel. These EPC-CM-depen-
dent morphogenic properties were clearly diminished by inhibition
of the PI3K/AKT and the MEK/ERK pathway (Fig. 6, 7).
Quantitative analyzes revealed that the incubation with EPC-CM
resulted in significantly wider total area covered by capillary-like
structures (2.6 fold), total tubule length (2 fold) and increased
number of branches (3.3 fold) as compared to control medium.
Concomitant treatment with [5 mM] LY294002 significantly
attenuated the total area covered by capillary-like structures, total
tubular length and number of branches induced by EPC-CM.
Similarly, the presence of [10 mM] PD98059 significantly reduced
the total area covered by capillary-like structures and total tubular
length induced by EPC-CM. Notably, inhibition of the MEK/
ERK pathway attenuated number of branches induced by EPC-
CM but the difference did not reach statistical significance (Fig. 6,
7).
EPC-CM supports angiogenesis through PI3K/AKT and
MEK/ERK activation
Based on the outcome of the PI3K/AKT and MEK/ERK
pathway inhibition experiments using the rBCEC4 cell line we
reasoned whether similar effects could be reproduced on tissue
explants. Hence, we used the well established aortic ring assay to
monitor the involvement of the PI3K/AKT and MEK/ERK
pathways on EPC-CM induced angiogenesis.
Figure 4. EPC-CM-induced rBCEC4 viability is AKT and ERK
dependent. rBCEC4 incubated with EPC-CM (CM) displayed higher
viable cell numbers assessed with the Presto Blue assay as compared to
control (Ctr). The EPC-CM induced higher viable cell number was
inhibited by AKT (CM+LY) as well as ERK (CM+PD) phosphorylation
inhibitors ([5 mM] and [10 mM], respectively). Data are given as mean +
s.e.m. and values are presented as percentage of control. *: p , 0.05.
doi:10.1371/journal.pone.0095731.g004
Figure 5. EPC-CM-induced rBCEC4 migration is AKT and ERK
dependent. Representative microphotographs (upper panels) and
quantitative analysis (lower panel) of rBCEC4 wound healing capacity.
rBCEC4 incubated with EPC-CM (CM) displayed higher migration rate in
the wound healing-scratch test as compared to control (Ctr). Scale bar:
100 mm. EPC-CM induced migration was inhibited by AKT (CM+LY) as
well as ERK (CM+PD) phosphorylation inhibitors ([5 mM] and [10 mM],
respectively). Data are given as mean + s.e.m. and values are presented
as percentage of control. *: p , 0.05.
doi:10.1371/journal.pone.0095731.g005
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Accordingly with previously published data [11], length of
sprouts emerging from the aortic wall was significantly higher in
the EPC-CM treated group (2.9 fold) as compared to the control.
This pro-angiogenic effect of EPC-CM was completely abrogated
by the presence of the PI3K/AKT inhibitor ([5 mM]) and
significantly attenuated by the supplementation of the MEK/
ERK inhibitor ([10 mM]) (Fig. 8, 9).
Discussion
EPC contribute to the maintenance of the endothelial integrity
and the vascular growth. For these relevant characteristics, EPC
are considered a promising therapeutic tool for vascular medicine
and tissue regeneration [27]. There is now compelling evidence
that the cytoprotective and angiogenic properties of EPC
substantially rely on paracrine mechanisms [28–30]. We have
previously demonstrated that soluble factors secreted by EPC
induce a protective response in cultured endothelial cells [13] and
display potent angiogenic effects in an animal model of chronic
muscle ischemia [11]. The present study further extends these
observations and provides important clues on the mechanisms of
action underlying the effects of the soluble factors secreted by
EPC. Specifically, we report that in the brain microvascular
endothelial cell line rBCEC4 the PI3K/AKT and the MEK/ERK
pathways play a fundamental role in transducing the angiogenic
cues conveyed by the EPC-paracrine factors.
The identification of the array of factors secreted by EPC is still
object of intense investigation [12,15,31]. We and others have
previously documented the presence of several growth factors and
cytokines in EPC-CM [7,11] and in the present work we
consistently report the increased level of angiogenic factors in
EPC-CM as result of hypoxic conditioning. Overall, EPC-CM has
Figure 6. Angiogenic potential of EPC-CM on tubular structure
formation. Representative microphotographs of tubular network
formation by microvascular endothelial cells on growth factor reduced
Matrigel. EPC-CM incubation (CM) strikingly promoted the tube-like
structure formation as compared to control medium (Ctr). Supplemen-
tation of EPC-CM with the inhibitor of AKT phosphorylation (CM+LY)
([5 mM]) substantially attenuated EPC-CM induced tube formation.
Similarly, addition of the inhibitor of ERK phosphorylation (CM+PD)
([10 mM]) resulted in a decrease of tube formation, however, to a lesser
degree as compared to the CM+LY group. Scale bar: 100 mm.
doi:10.1371/journal.pone.0095731.g006
Figure 7. EPC-CM effects on tubular structure formation are AKT and ERK dependent. Quantitative analysis of tubular network formation
by microvascular endothelial cells on growth factor reduced Matrigel. EPC-CM incubation (CM) significantly promoted total area covered by the tube-
like structures (A), total sprout length (B) and branching (C) as compared to control medium (Ctr). Supplementation of EPC-CM with the inhibitor of
AKT phosphorylation (CM+LY) ([5 mM]) substantially attenuated all three parameters while the addition of the inhibitor of ERK phosphorylation
(CM+PD) ([10 mM]) resulted in a significant decrease of covered area and total tube length but had no significant effect on the reduction of the
number of branches. Data are given as mean + s.e.m. and values are presented as percentage of corresponding controls. *: p , 0.05.
doi:10.1371/journal.pone.0095731.g007
Figure 8. Angiogenic potential of EPC-CM on ex vivo aortic
rings. Representative microphotographs of vascular outgrowth from
rat aortic rings embedded in growth factor reduced-Matrigel. Incuba-
tion with EPC-CM (CM) enhanced the formation of vascular outgrowth
from the aortic rings compared to control medium incubation (Ctr).
EPC-CM-enhanced capillary outgrowth was abolished by the addition of
[5 mM] LY294002 (CM+LY). Similarly, incubation with EPC-CM in
presence of [10 mM] PD98509 (CM+PD) significantly impaired total
sprout length induced by EPC-CM. Scale bars: 200 mm and 100 mm
(inserts).
doi:10.1371/journal.pone.0095731.g008
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been found to promote survival, morphogenesis and migration of
endothelial cells [13,32]. At the intracellular signaling level, it is
conceivable that these cellular responses result from concomitant
activation of different pathways in turn induced by the plethora of
factors contained in EPC-CM. Indeed, factors secreted from EPC
into the medium like VEGF and EGF among many others can
activate AKT and ERK pathways which are pivotal signaling steps
in angiogenesis [33,34]. In line with this observation and
consistently with the data reported here, Xia and colleagues
described that the activation of AKT as well as of ERK by EPC
soluble factors resulted in increased proliferation and reduced
apoptosis of lung microvascular endothelial cells [35]. Likewise, it
has been shown that AKT activation by umbilical cord monocyte-
derived paracrine factors is indispensable to confer protection
against coronary artery endothelial cell apoptosis [36].
In the frame of studies addressing the paracrine signals, great
emphasis is usually given to growth factors and cytokines. Indeed,
the successful identification of the key element of stem/progenitor
cells secretome has been reported [37,38] while our previous
findings suggest that synergic action of multiple factors might also
account for the effects of EPC-CM [13,24]. However, it should be
kept in mind that proteins are not the sole constituents of
conditioned media. Hence, in the present study it cannot be
excluded that non-proteiceous compounds might participate at
least in part in influencing the endothelial cell activity reported
here. Among the different molecules that can be found in the
conditioned medium, the compounds of the cellular metabolism as
citrate [39], ATP [40] or 20-Hydroxyeicosatetraenoic acid (20-
HETE, an eicosanoid) [41] have been shown to promote
angiogenesis directly activating AKT and ERK or synergizing
growth factors action. Hence, the dissection of conditioned
medium components and signaling pathway activation in target
cells can be considered the two sides of the same coin.
The capacity to elicit angiogenic and cytoprotective actions
through paracrine factors is not a unique feature of EPC. In fact, it
has been reported that conditioned medium from mononuclear
cells [42,43], embryonic stem cells [44], mesenchymal stem cells
[45–49] promoted vascular growth and endothelial cell as well as
cardiomyocytes survival and migration. Noteworthy, these secre-
tome-induced actions involved primarily the activation of the
PI3K/AKT pathway [44,45]. On the other hand, the MEK/ERK
pathway, despite induction, seems to play a less relevant role in
driving the angiogenic program promoted by paracrine factors
[45]. These findings are overall in line with the results reported
here. Specifically, in our experimental settings we observed that
EPC-CM promoted all the angiogenic activities tested and
involved AKT activation. Differently, even though the ERK
pathway was significantly involved, it appears to have a slightly
smaller impact particularly on viable cell numbers and on capillary
sprouting in the aortic ring assay. It is likely that the different
outcome in terms of viable endothelial cells resulting from AKT or
ERK inhibition accounts, at least in part, for the shorter sprout
length observed in the aortic ring assay. More studies are needed
to define the responses of the different cell types present in the
aortic wall to EPC-CM including fibroblast, mural cells and
macrophages [50].
The angiogenic properties of EPC-CM on rBCEC4 reported
here are consistent with previous works employing endothelial cells
of different origins. In these studies a similar response of to EPC-
CM with regards to proliferation, migration and capillary network
formation in vitro has been outlined [13,32,35,36]. Current data
suggest that the effects of EPC-CM might go beyond survival of
local endothelial cells. In fact it has been reported that AKT and
ERK activated endothelial cells in bone marrow differently
modulate hematopoietic stem cells self-renewal and differentiation
[51]. It is thus possible that a bidirectional crosstalk between
endothelial cells and EPC through soluble factors might take place
also in the periphery of the circulatory system and have a relevant
role in tissue homeostasis.
It is clear that the restoration of appropriate perfusion and brain
blood vessels functionality are essential to treat conditions like
ischemic stroke. Noteworthy, several lines of evidence suggest that
vascular impairment plays a substantial role in the pathogenesis of
neurodegenerative disorders like Alzheimer and Parkinson diseases
[19,20]. Thus, interventions targeting the endothelium might offer
new therapeutic options for neuronal repair in a wide range of
diseases. In the present study a rat cell line was deliberately chosen
to assess the response of EPC-CM of human origin in view of
future application of EPC-CM in rat models of neurodegenerative
conditions. It has been reported that rBCEC4 cells preserve many
properties of primary cells and are phenotypically stable [22] and
are useful tools for studies involving interactions between the
endothelium and the surrounding neuronal tissue [52]. The
present work supports the concept of a therapeutic approach based
on EPC-derived secretome for the treatment of conditions
involving endothelial dysfunction and to the best of our knowledge
it is the first study addressing the effect of factors secreted by EPC
on brain microvascular endothelial cells.
In summary, the present study adds further evidence of the
angiogenic potential of EPC-CM and provides the basis of
understanding mechanisms of action of EPC by paracrine
secretion.
Supporting Information
Figure S1 Time course of AKT and ERK phosphorylation.
Representative immunoblots of the time course of AKT and ERK
phosphorylation in rBCEC4 cells treated with EPC-CM. The level
of AKT and ERK phosphorylation peaks at 15 minutes (159) of
incubation with EPC-CM and gradually declines to the control
(Ctr) level after 16 hours (16 hr).
(TIF)
Figure 9. EPC-CM effects on total sprout length of ex vivo aortic
rings are AKT and ERK dependent. Quantitative analysis of vascular
outgrowth from rat aortic rings embedded in growth factor reduced-
Matrigel. Incubation with EPC-CM (CM) enhanced total sprout length
from the aortic rings compared to control medium incubation (Ctr). This
effect was significantly abolished by addition of [5 mM] LY294002
(CM+LY) as well as of [10 mM] PD98509 (CM+PD). Data are given as
mean + s.e.m. and values are presented as percentage of control. *: p ,
0.05.
doi:10.1371/journal.pone.0095731.g009
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